Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma

Successful treatment with allogeneic bone marrow transplant

L. R. Rogers, N. Janakiraman, Claude Sportes, M. L. Rosenblum

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective and importance: Therapy-related myelodysplastic syndrome (t-MDS) is a rare and typically fatal complication of therapy for cancer, including brain tumors. We report successful therapy of t-MDS that developed after treatment for an anaplastic astrocytoma. Clinical presentation: t-MDS developed four and one-half years after successful therapy (resection, radiation and chemotherapy) administered for a cerebral anaplastic astrocytoma in a 34-year-old patient. Intervention: The patient was treated with allogeneic bone marrow transplant (BMT) for t-MDS. Conclusion: She is alive three years after BMT with no evidence of brain tumor and in complete remission from t-MDS. To our knowledge, this is the first report of allogeneic BMT administered for t-MDS in an adult brain tumor patient. Clinicians must be alert to the development of t-MDS following chemotherapy for brain tumors and initiate appropriate treatment promptly.

Original languageEnglish (US)
Pages (from-to)55-59
Number of pages5
JournalJournal of Neuro-Oncology
Volume53
Issue number1
DOIs
StatePublished - Oct 16 2001
Externally publishedYes

Fingerprint

Myelodysplastic Syndromes
Astrocytoma
Bone Marrow
Transplants
Brain Neoplasms
Therapeutics
Drug Therapy
Radiotherapy

Keywords

  • Antineoplastic agents
  • Brain neoplasms
  • Leukemia
  • Myelodysplastic syndromes

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neuroscience(all)

Cite this

Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma : Successful treatment with allogeneic bone marrow transplant. / Rogers, L. R.; Janakiraman, N.; Sportes, Claude; Rosenblum, M. L.

In: Journal of Neuro-Oncology, Vol. 53, No. 1, 16.10.2001, p. 55-59.

Research output: Contribution to journalArticle

@article{82caba672d994ee38ff5e8d896fbec5d,
title = "Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma: Successful treatment with allogeneic bone marrow transplant",
abstract = "Objective and importance: Therapy-related myelodysplastic syndrome (t-MDS) is a rare and typically fatal complication of therapy for cancer, including brain tumors. We report successful therapy of t-MDS that developed after treatment for an anaplastic astrocytoma. Clinical presentation: t-MDS developed four and one-half years after successful therapy (resection, radiation and chemotherapy) administered for a cerebral anaplastic astrocytoma in a 34-year-old patient. Intervention: The patient was treated with allogeneic bone marrow transplant (BMT) for t-MDS. Conclusion: She is alive three years after BMT with no evidence of brain tumor and in complete remission from t-MDS. To our knowledge, this is the first report of allogeneic BMT administered for t-MDS in an adult brain tumor patient. Clinicians must be alert to the development of t-MDS following chemotherapy for brain tumors and initiate appropriate treatment promptly.",
keywords = "Antineoplastic agents, Brain neoplasms, Leukemia, Myelodysplastic syndromes",
author = "Rogers, {L. R.} and N. Janakiraman and Claude Sportes and Rosenblum, {M. L.}",
year = "2001",
month = "10",
day = "16",
doi = "10.1023/A:1011878214861",
language = "English (US)",
volume = "53",
pages = "55--59",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Therapy-related myelodysplastic syndrome (t-MDS) in a patient with anaplastic astrocytoma

T2 - Successful treatment with allogeneic bone marrow transplant

AU - Rogers, L. R.

AU - Janakiraman, N.

AU - Sportes, Claude

AU - Rosenblum, M. L.

PY - 2001/10/16

Y1 - 2001/10/16

N2 - Objective and importance: Therapy-related myelodysplastic syndrome (t-MDS) is a rare and typically fatal complication of therapy for cancer, including brain tumors. We report successful therapy of t-MDS that developed after treatment for an anaplastic astrocytoma. Clinical presentation: t-MDS developed four and one-half years after successful therapy (resection, radiation and chemotherapy) administered for a cerebral anaplastic astrocytoma in a 34-year-old patient. Intervention: The patient was treated with allogeneic bone marrow transplant (BMT) for t-MDS. Conclusion: She is alive three years after BMT with no evidence of brain tumor and in complete remission from t-MDS. To our knowledge, this is the first report of allogeneic BMT administered for t-MDS in an adult brain tumor patient. Clinicians must be alert to the development of t-MDS following chemotherapy for brain tumors and initiate appropriate treatment promptly.

AB - Objective and importance: Therapy-related myelodysplastic syndrome (t-MDS) is a rare and typically fatal complication of therapy for cancer, including brain tumors. We report successful therapy of t-MDS that developed after treatment for an anaplastic astrocytoma. Clinical presentation: t-MDS developed four and one-half years after successful therapy (resection, radiation and chemotherapy) administered for a cerebral anaplastic astrocytoma in a 34-year-old patient. Intervention: The patient was treated with allogeneic bone marrow transplant (BMT) for t-MDS. Conclusion: She is alive three years after BMT with no evidence of brain tumor and in complete remission from t-MDS. To our knowledge, this is the first report of allogeneic BMT administered for t-MDS in an adult brain tumor patient. Clinicians must be alert to the development of t-MDS following chemotherapy for brain tumors and initiate appropriate treatment promptly.

KW - Antineoplastic agents

KW - Brain neoplasms

KW - Leukemia

KW - Myelodysplastic syndromes

UR - http://www.scopus.com/inward/record.url?scp=0034789478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034789478&partnerID=8YFLogxK

U2 - 10.1023/A:1011878214861

DO - 10.1023/A:1011878214861

M3 - Article

VL - 53

SP - 55

EP - 59

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -